Greg Andrew Durm

Also affiliated with Indiana University – Purdue University Indianapolis

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Analysis of Circulating Tumor DNA Predicts Outcomes of Short-Course Consolidation Immunotherapy in Unresectable Stage III NSCLC”.

Analysis of Circulating Tumor DNA Predicts Outcomes of Short-Course Consolidation Immunotherapy in Unresectable Stage III NSCLC

Journal of Thoracic Oncology(2024)10.1016/j.jtho.2024.06.024

N/A

0.972DataRank · unranked

29 citations

Nikhil Shukla, Greg Andrew Durm, Angela Bik‐Yu Hui, Sha Cao, Apar Kishor Ganti +6 more

Evaluation of Radiation Pneumonitis in a Phase 2 Study of Consolidation Immunotherapy With Nivolumab and Ipilimumab or Nivolumab Alone Following Concurrent Chemoradiation Therapy for Unresectable Stage IIIA/IIIB Non-Small Cell Lung Cancer

International Journal of Radiation Oncology*Biology*Physics(2024)10.1016/j.ijrobp.2024.09.050

N/A

0.345DataRank · unranked

9 citations

Greg Andrew Durm, Misty Dawn Shields, Nasser H. Hanna, Sandra K. Althouse, Tim Lautenschlaeger +1 more

Analysis of circulating tumor DNA in the phase 2 BTCRC LUN 16-081 trial of consolidation nivolumab with or without ipilimumab after chemoradiation in stage III non–small cell lung cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.8534

N/A

0.312DataRank · unranked

7 citations

Nikhil Shukla, Greg Andrew Durm, Angela BY Hui, Sha Cao, Christian A. Kunder +4 more